BD makes strategic review of respiratory business unit to pay off debts

Becton Dickinson (BD) following the acquisition of CareFusion, is mulling selling its respiratory business segment, which would help pay off its debts owed during the acquisition of CareFusion. The respiratory business unit, which was formerly part of CareFusion, is expected to be valued around USD 1.5 – 2 billion. Becton Dickinson debited USD 6.2 billion to finance the CareFusion acquisition deal. Becton Dickinson owes USD 750 million payment in June 2016, following another USD 1.25 billion payment in December 2017. With the acquisition of CareFusion, Becton Dickinson is now more focused on hospitals with more concentration on medication management. The industry spokesperson mentioned that the strategic fit will evolve BD as one of the biggest medical device players across the globe.